HomeBVAXF • OTCMKTS
add
Biovaxys Technology Corp
Previous close
$0.22
Day range
$0.18 - $0.21
Year range
$0.029 - $0.60
Market cap
7.63M CAD
Avg Volume
51.68K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 859.08K | 7.09% |
Net income | -910.06K | 23.30% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.08K | -99.17% |
Total assets | 1.39M | -42.41% |
Total liabilities | 5.03M | 89.24% |
Total equity | -3.64M | — |
Shares outstanding | 29.15M | — |
Price to book | -1.83 | — |
Return on assets | -172.72% | — |
Return on capital | 70.36% | — |
Cash Flow
Net change in cash
| (CAD) | Jul 2025info | Y/Y change |
|---|---|---|
Net income | -910.06K | 23.30% |
Cash from operations | -1.06M | -156.33% |
Cash from investing | 1.06M | 105,636,400.00% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -229.00 | -100.07% |
Free cash flow | 1.43M | 249.91% |
